Quick Answer
ProMIS Neurosciences Inc. reported Shares Outstanding of 2.15 million shares for fiscal year 2025.
ProMIS Neurosciences Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 2.15M | +64.6% |
| 2024 | 1.31M | -93.1% |
| 2023 | 18.89M | +120.1% |
| 2022 | 8.58M | +19.2% |
| 2021 | 7.20M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 53.81M | +64.6% | +64.6% |
| June 30, 2025 | 32.69M | +72.4% | +0.0% |
| March 31, 2025 | 32.69M | +72.4% | +0.0% |
| December 31, 2024 | 32.69M | +73.1% | +0.0% |
| September 30, 2024 | 32.69M | +76.5% | +72.4% |
| June 30, 2024 | 18.96M | +121.0% | +0.0% |
| March 31, 2024 | 18.96M | +121.0% | +0.4% |
| December 31, 2023 | 18.89M | +120.1% | +1.9% |
- ProMIS Neurosciences Inc. showed an increase of +64.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, ProMIS Neurosciences Inc.’s shares outstanding has declined by 70.1% (from 7.20 million shares to 2.15 million shares).
- The most recent figure is from ProMIS Neurosciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: